VeriMom¿Es r-(aspartyl oligopeptide-162 hexapeptide-40 aspartyl rh-polypeptide-114)/r- (aspartyl oligopeptide-162 aspartyl rh-polypeptide-115)/r-( aspartyl oligopeptide-162 aspartyl rh-polypeptide-48) seguro durante el embarazo?
No harmonised CLP reproductive classifications (ECHA Annex VI) or SCCS/CIR findings indicating reproductive hazard for these cosmetic peptides. No peer‑reviewed evidence of teratogenicity or reproductive toxicity for these named oligopeptide/hexapeptide cosmetic ingredients was identified in available cosmetic safety sources, and peptides of this size are generally considered of low dermal absorption in topical use (CIR/CosIng/PubChem review).
Related ingredients
Frequently asked questions
- ¿Es r-(aspartyl oligopeptide-162 hexapeptide-40 aspartyl rh-polypeptide-114)/r- (aspartyl oligopeptide-162 aspartyl rh-polypeptide-115)/r-( aspartyl oligopeptide-162 aspartyl rh-polypeptide-48) seguro durante el embarazo?
- No harmonised CLP reproductive classifications (ECHA Annex VI) or SCCS/CIR findings indicating reproductive hazard for these cosmetic peptides. No peer‑reviewed evidence of teratogenicity or reproductive toxicity for these named oligopeptide/hexapeptide cosmetic ingredients was identified in available cosmetic safety sources, and peptides of this size are generally considered of low dermal absorption in topical use (CIR/CosIng/PubChem review).
- ¿Es r-(aspartyl oligopeptide-162 hexapeptide-40 aspartyl rh-polypeptide-114)/r- (aspartyl oligopeptide-162 aspartyl rh-polypeptide-115)/r-( aspartyl oligopeptide-162 aspartyl rh-polypeptide-48) seguro durante la lactancia?
- Same rationale as pregnancy: no harmonised classifications or authoritative cosmetic safety assessments indicating reproductive/lactation risk. Large peptide molecules used topically have low systemic availability; no data indicate transfer into breast milk or effects on nursing infants.
- ¿Es r-(aspartyl oligopeptide-162 hexapeptide-40 aspartyl rh-polypeptide-114)/r- (aspartyl oligopeptide-162 aspartyl rh-polypeptide-115)/r-( aspartyl oligopeptide-162 aspartyl rh-polypeptide-48) seguro para la piel del bebé?
- No evidence of intrinsic reproductive or developmental hazard. Mechanistic data lacking. Exposure score increased by +1 for infants (e=1) because, although adult dermal absorption is expected to be negligible for large peptides, infant skin has higher absorption potential and immature barrier function, so measurable exposure cannot be excluded.
- ¿Cómo puntúa VeriMom a r-(aspartyl oligopeptide-162 hexapeptide-40 aspartyl rh-polypeptide-114)/r- (aspartyl oligopeptide-162 aspartyl rh-polypeptide-115)/r-( aspartyl oligopeptide-162 aspartyl rh-polypeptide-48)?
- VeriMom puntúa r-(aspartyl oligopeptide-162 hexapeptide-40 aspartyl rh-polypeptide-114)/r- (aspartyl oligopeptide-162 aspartyl rh-polypeptide-115)/r-( aspartyl oligopeptide-162 aspartyl rh-polypeptide-48) en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a r-(aspartyl oligopeptide-162 hexapeptide-40 aspartyl rh-polypeptide-114)/r- (aspartyl oligopeptide-162 aspartyl rh-polypeptide-115)/r-( aspartyl oligopeptide-162 aspartyl rh-polypeptide-48) en el embarazo?
- Consulta nuestra lista de alternativas seguras a r-(aspartyl oligopeptide-162 hexapeptide-40 aspartyl rh-polypeptide-114)/r- (aspartyl oligopeptide-162 aspartyl rh-polypeptide-115)/r-( aspartyl oligopeptide-162 aspartyl rh-polypeptide-48) según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.